FDA Approves Unknown Drug — SABA ILAC SANAYIVE
SABA ILAC SANAYIVE has secured FDA approval for ANDA 217934, a milestone that is expected to expand the manufacturer's commercial portfolio and provide a solid foundation for future market growth.
AI-generated summary for informational purposes only. Always verify against the original filing. Not investment advice. BriefTape is not a registered investment adviser.
Get real-time financial news in your trading bot or app
GET FREE KEY — 10,000 calls/day